fake glp-1 Dissing Disinformation Inside Europe's AI-Fuelled GLP-1 Scam

Johnson and Kenny, 2010

When thinking about weight loss injections, it's important to consider several factors

The uncomfortable truths we need to talk about As someone whos spent two decades in wealth management, Ive learned that the most important conversations are often the uncomfortable ones

Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al

Canada became the first G7 country to approve a generic semaglutide in April 2026, after Novo Nordisk failed to maintain a key Canadian patent covering acylated GLP-1 compounds

Off-label use for weight management in non-diabetic individuals is common in clinical practice, but this use lacks formal regulatory approval